Agios pharmaceuticals, inc. (AGIO)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Dec'12
Assets
Current assets:
Cash and cash equivalents

89,093

80,931

81,709

83,580

103,443

70,502

156,478

210,323

364,469

102,724

132,741

138,717

200,278

160,754

285,502

234,048

39,035

71,764

80,048

72,533

35,256

14,031

70,049

108,247

32,837

71,560

106,011

77,481

91,297

Marketable securities

439,528

483,946

370,188

411,810

421,114

514,800

513,414

506,582

417,981

321,212

375,187

447,325

279,480

380,560

293,595

231,321

273,859

245,238

272,317

297,261

309,450

328,034

149,921

130,233

129,432

95,209

88,945

21,794

36,679

Accounts receivable, net

11,813

8,952

7,106

7,147

4,355

5,076

2,631

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Collaboration receivable – related party

2,577

1,539

1,838

2,524

2,319

2,462

3,395

19,326

3,512

2,448

3,489

4,842

11,265

4,886

8,182

7,853

6,814

8,225

9,078

10,474

7,017

6,492

18,759

-

-

476

-

-

-

Collaboration receivable – other

2,033

1,928

869

2,222

1,640

670

440

440

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Royalty receivable – related party

3,300

2,900

2,600

2,700

2,200

2,234

1,863

1,573

1,417

1,222

715

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventory

9,778

7,331

5,849

4,659

2,328

869

863

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Tenant improvement and other receivables

-

-

-

-

-

-

-

-

-

-

859

779

3,452

3,428

3,387

2,014

571

3,374

2,992

5,282

6,906

2,334

-

-

-

-

-

-

-

Unbilled collaboration receivable - related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,619

-

-

-

-

Prepaid expenses and other current assets

29,152

24,177

19,985

19,063

19,696

17,167

16,458

15,538

15,614

17,655

15,316

13,018

12,391

10,264

10,277

8,923

9,190

8,728

7,225

4,602

5,512

4,814

4,990

2,842

3,033

2,502

2,616

2,011

922

Refundable income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,841

3,841

3,841

4,496

-

-

-

-

Deferred tax assets, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,246

1,247

1,246

Total current assets

587,274

611,704

490,144

533,705

557,095

613,780

695,542

753,782

802,993

445,261

528,307

604,681

506,866

559,892

600,943

484,159

329,469

337,329

371,660

390,152

364,141

359,546

247,560

245,163

172,417

169,747

198,818

102,533

130,144

Marketable securities

84,503

152,929

88,579

128,649

183,234

220,119

208,508

219,724

212,297

143,814

133,804

129,899

23,423

32,250

43,499

46,926

42,860

58,905

55,621

64,243

95,258

125,382

17,917

22,631

5,005

27,125

13,412

-

-

Operating lease assets

91,440

93,643

95,833

98,500

57,768

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Property and equipment, net

33,840

31,472

24,060

23,016

23,974

24,320

24,613

24,134

23,732

24,431

24,019

24,771

24,139

25,337

26,261

25,134

22,950

23,220

21,127

19,328

14,297

6,386

3,677

3,210

3,452

3,758

3,551

3,818

3,565

Financing lease assets

881

993

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

571

571

571

571

571

571

Deferred tax assets, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,706

2,706

2,706

Other assets

1,800

0

0

0

60

238

416

595

1,104

891

1,070

1,249

2,888

1,615

1,339

1,382

838

611

678

660

640

590

454

455

467

4

11

1,624

22

Total assets

799,738

890,741

698,616

783,870

822,131

858,457

929,079

998,235

1,040,126

614,397

687,200

760,600

557,316

619,094

672,042

557,601

396,117

420,065

449,086

474,383

474,336

491,904

269,608

272,030

181,912

201,205

219,069

111,252

137,008

Liabilities and stockholders’ equity
Current liabilities:
Accounts payable

18,707

21,896

21,511

15,435

12,413

17,880

16,616

17,320

17,932

22,767

17,899

23,409

16,152

17,106

15,424

18,448

13,746

14,748

8,971

8,914

12,640

11,067

6,225

5,388

4,411

3,678

2,140

3,038

3,308

Accrued expenses

39,631

53,142

46,750

49,218

37,199

42,147

25,303

25,793

17,005

34,031

30,760

29,641

25,114

32,002

22,808

14,414

12,247

15,996

15,985

11,584

15,604

14,020

10,004

5,456

3,841

6,586

4,764

3,586

1,708

Deferred revenue – related party

4,748

10,933

16,873

18,454

22,167

32,710

42,141

41,132

39,212

37,842

35,867

37,069

37,690

35,913

36,415

31,469

16,523

19,665

22,650

22,608

6,886

35,686

18,847

33,644

25,072

25,072

25,072

25,072

25,072

Operating lease liabilities

6,466

6,642

7,298

6,397

9,128

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income taxes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,462

5,257

5,141

4,875

Financing lease liabilities

306

273

0

0

0

766

686

625

550

301

3,586

3,529

3,473

3,412

3,356

2,933

2,539

2,479

2,150

2,092

1,245

310

-

142

133

123

-

104

85

Other current liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4

6

8

8

624

9

144

-

-

Restricted stock liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

38

65

Total current liabilities

69,858

92,886

92,432

89,504

80,907

93,503

84,746

84,870

74,699

94,941

88,112

93,648

82,429

88,433

78,003

67,264

45,055

52,888

49,756

45,198

36,379

61,089

35,084

44,638

34,081

36,930

37,377

36,979

35,113

Deferred revenue, net of current portion – related party

0

50,580

49,797

51,616

54,961

59,809

66,294

72,408

81,831

125,798

134,202

141,957

150,596

154,297

173,941

183,540

1,949

4,699

6,240

9,389

133

2,725

26,352

26,697

26,299

32,567

38,835

45,103

57,639

Operating lease liabilities, net of current portion

104,010

106,074

108,096

110,073

66,006

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Financing lease liabilities, net of current portion

571

673

0

0

0

17,608

17,826

17,815

18,002

18,155

15,080

16,003

16,911

17,773

18,649

17,719

16,740

17,360

17,433

15,631

11,007

3,724

423

145

186

220

-

288

343

Total liabilities

174,439

250,213

250,325

251,193

201,874

170,920

168,866

175,093

174,532

238,894

237,394

251,608

-

260,503

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other non-current liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

3

6

262

-

-

Restricted stock liability, net of current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10

15

Commitments and contingent liabilities (Note 9)

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

0

0

0

0

-

0

0

Stockholders’ equity:
Preferred stock, $0.001 par value; 25,000,000 shares authorized; no shares issued or outstanding at March 31, 2020 and December 31, 2019

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

0

Preferred stock

0

0

0

0

0

0

0

0

0

0

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

Common stock, $0.001 par value; 125,000,000 shares authorized; 68,789,925 and 68,401,105 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

69

68

59

59

59

58

58

58

58

49

49

48

42

42

42

38

38

38

38

37

37

37

35

34

32

31

31

4

3

Additional paid-in capital

2,181,517

2,156,363

1,861,523

1,839,710

1,818,393

1,794,283

1,775,113

1,743,657

1,717,609

1,174,904

1,160,048

1,142,233

857,107

842,013

828,043

652,574

640,124

630,078

619,451

607,708

598,494

591,334

347,947

344,490

246,970

244,881

243,601

2,836

2,012

Accumulated other comprehensive income

74

202

464

490

-484

-2,171

-2,119

-2,398

-2,643

-1,389

-515

-650

-212

-313

29

297

89

-318

225

222

191

-57

51

12

33

14

25

-5

-2

Accumulated deficit

-1,556,361

-1,516,105

-1,413,755

-1,307,582

-1,197,711

-1,104,633

-1,012,839

-918,175

-849,430

-798,061

-709,776

-632,639

-549,557

-483,151

-426,665

-363,831

-307,878

-284,680

-244,057

-203,802

-171,905

-166,948

-140,284

-143,988

-125,692

-113,444

-101,062

-89,885

-74,037

Total stockholders’ equity

625,299

640,528

448,291

532,677

620,257

687,537

760,213

823,142

865,594

375,503

449,806

508,992

307,380

358,591

401,449

289,078

332,373

345,118

375,657

404,165

426,817

424,366

207,749

200,548

121,343

131,482

142,595

-87,050

-72,024

Total liabilities and stockholders’ equity

799,738

890,741

698,616

783,870

822,131

858,457

929,079

998,235

1,040,126

614,397

687,200

760,600

557,316

619,094

672,042

557,601

396,117

420,065

449,086

474,383

474,336

491,904

269,608

272,030

181,912

201,205

219,069

111,252

137,008